Just Earth News | @justearthnews | 20 Mar 2022, 03:32 am Print
Omicron Pixabay
Moscow/UNI/Sputnik: The new Russian nasal vaccine against the coronavirus infection has demonstrated effectiveness against the Omicron variant, Alexander Gintsburg, the director of Russia's Gamaleya Research Center for Epidemiology and Microbiology, told Sputnik.
"Yes, it is being tested against Omicron, it works," Gintsburg said. According to the chief researcher, the new vaccine will be used as a booster, in addition to the Sputnik V shots, for now, until there is enough evidence that this new intranasal vaccine gives the same level of protection as injection.
The Russian health ministry authorized clinical trials of the new intranasal vaccine in October 2021.
In November, Russian President Vladimir Putin offered to become a volunteer in the testing of the new vaccine and said that he felt no side effects after getting the procedure.
Gintsburg told Sputnik earlier this month that the new intranasal vaccine had already been administered to over 100 people, as part of the trials, who showed no negative side effects.
On Friday, the Gamaleya center applied for the registration of the new nasal vaccine against Covid-19. According to Gintsburg, it is expected to be registered earlier than planned.
- Avian flu reported in 108 countries, alerts UN health agency
- Birth registration increases, but 150 million children still ‘invisible’, shows new UNICEF report
- WHO alerts over 1 in 5 adults worldwide has a genital herpes infection
- New study shows short-term cognitive boost from exercise may last for 24 hours, new study reveals
- Bird flu may emerge as next global pandemic, warn experts
